Abstract

BackgroundCampylobacter spp. infections are a globally important cause of enterocolitis, causing substantial morbidity. Capturing accurate information on hospitalisations is challenging and limited population-level data exist to describe the clinico-epidemiological characteristics of hospitalised cases.MethodsHospital administrative and laboratory datasets were linked to identify Campylobacter-associated hospitalisations between 2004 and 2013. Accuracy of morbidity coding was assessed using laboratory diagnosis as a gold standard, with health department surveillance data used to calculate population-based rates. Additional patient-level data were collected via review of medical records. Descriptive statistics were used to assess changes in rates and proportions and to assess relationships between key variables including age, length of stay, comorbidity and complications.ResultsIn total 685 Campylobacter-associated hospital admissions were identified, with the sensitivity of morbidity coding 52.8% (95% CI 48.9–56.7%). The mean annual rate of hospitalisation was 13.6%. Hospitalisation rates were higher for females across most age-groups, while for both genders marked increases were observed for those aged ≥60 years. Median admission age was 39.5 years, with an average length of stay of 3.5 days. Comorbidities were present in 34.5% (237/685) of admissions, with these patients more likely to develop electrolyte disturbances, hypotension, renal impairment or acute confusion (all p < 0.001). Bacteraemia and acute kidney injury were observed in 4.1% (28/685) and 3.6% (23/685) of admissions, respectively. Inpatient mortality was low (0.15%).ConclusionUnder reporting of Campylobacter-associated hospitalisations is substantial but can be improved through data linkage. We observed demographic differences among those hospitalised but further work is needed to determine risk factors and predictors for hospitalisation.

Highlights

  • Campylobacter spp. infections are a globally important cause of enterocolitis, causing substantial morbidity

  • Linking hospital administrative data to laboratory data We identified 685 Campylobacter-associated admissions during the study period (Fig. 1)

  • For admissions identified via administrative data, 84% (300/359) had Campylobacter enteritis recorded as a primary diagnosis code

Read more

Summary

Introduction

Campylobacter spp. infections are a globally important cause of enterocolitis, causing substantial morbidity. Capturing accurate information on hospitalisations is challenging and limited population-level data exist to describe the clinico-epidemiological characteristics of hospitalised cases. In high-income settings, Campylobacter spp. are the most frequently reported bacterial enteric pathogen, with increasing disease incidence observed in the United States (US), European Union and Australia [1,2,3]. National (and provincial-level) enteric surveillance systems are frequently passive, capturing only limited data on outcomes such as hospitalisation and death [8]. Given increasing disease incidence and concerns regarding accuracy of estimates, it is important to re-examine Campylobacter, with the aim of this study to quantify associated hospitalisations and describe their epidemiological and clinical characteristics, including the spectrum of illness, risk factors and associated outcomes

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call